COVID-19

• Clinical Features
  • Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. -- PIIS0140673620301835
• IL-6
  • COVID-19- consider cytokine storm symdromes and immunosuppression-- PIIS0140673620306280.pdf
  • Tocilizumab treatment in COVID-19- a single center experience.pdf
  • Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure- a case report.pdf
• Thromboembolic Disease (PE, VTE, ACS, others)
  • Journal Pre-Proof: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
  • Journal Pre-Proof: Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19